Benefits and Harms of Phosphate Binders in CKD: A Systematic Review of Randomized Controlled Trials
- 31 October 2009
- journal article
- research article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 54 (4), 619-637
- https://doi.org/10.1053/j.ajkd.2009.06.004
Abstract
No abstract availableThis publication has 72 references indexed in Scilit:
- Oral phosphate bindersKidney International, 2009
- Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisThe New England Journal of Medicine, 2009
- Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)American Journal of Kidney Diseases, 2008
- Hyperphosphatemia of chronic kidney diseaseKidney International, 2008
- A Comparison of Sevelamer and Calcium-Based Phosphate Binders on Mortality, Hospitalization, and Morbidity in Hemodialysis: A Secondary Analysis of the Dialysis Clinical Outcomes Revisited (DCOR) Randomized Trial Using Claims DataAmerican Journal of Kidney Diseases, 2008
- Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patientsKidney International, 2007
- Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patientsKidney International, 2007
- A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United StatesKidney International, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986